Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke | Zendy

Hamidreza Saber | Zendy; Jayandra J. Himali | Zendy; Alexa S. Beiser | Zendy; Ashkan Shoamanesh | Zendy; Aleksandra Pikula | Zendy; Ronenn Roubenoff | Zendy; José R. Romero | Zendy; Carlos S. Kase | Zendy; Ramachandran S. Vasan | Zendy; Sudha Seshadri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke

Author(s) -

Hamidreza Saber,

Jayandra J. Himali,

Alexa S. Beiser,

Ashkan Shoamanesh,

Aleksandra Pikula,

Ronenn Roubenoff,

José R. Romero,

Carlos S. Kase,

Ramachandran S. Vasan,

Sudha Seshadri

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.016563

Subject(s) - medicine , ischemic stroke , risk factor , stroke (engine) , insulin like growth factor , insulin , diabetes mellitus , cardiology , growth factor , endocrinology , ischemia , receptor , mechanical engineering , engineering

Low insulin-like growth factor 1 (IGF-1) has been associated with increased risk of atherosclerosis and atrial fibrillation in cross-sectional studies. Yet, prospective data linking IGF-1 levels to the development of ischemic stroke remain inconclusive. We examined prospectively the association between serum IGF-1 levels and incident ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research